- Home
- KIM vs HOLX Comparison
KIM vs HOLX Comparison
Compare KIM & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIM
- HOLX
- Stock Information
- Founded
- KIM 1958
- HOLX 1985
- Country
- KIM United States
- HOLX United States
- Employees
- KIM N/A
- HOLX N/A
- Industry
- KIM Real Estate Investment Trusts
- HOLX Medical Electronics
- Sector
- KIM Real Estate
- HOLX Health Care
- Exchange
- KIM Nasdaq
- HOLX Nasdaq
- Market Cap
- KIM 15.2B
- HOLX 14.8B
- IPO Year
- KIM 1991
- HOLX 1990
- Fundamental
- Price
- KIM $22.36
- HOLX $63.80
- Analyst Decision
- KIM Buy
- HOLX Buy
- Analyst Count
- KIM 12
- HOLX 13
- Target Price
- KIM $24.83
- HOLX $76.27
- AVG Volume (30 Days)
- KIM 3.4M
- HOLX 1.5M
- Earning Date
- KIM 10-30-2025
- HOLX 11-03-2025
- Dividend Yield
- KIM 4.46%
- HOLX N/A
- EPS Growth
- KIM 56.53
- HOLX N/A
- EPS
- KIM 0.82
- HOLX 2.41
- Revenue
- KIM $2,094,828,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- KIM $4.86
- HOLX $3.37
- Revenue Next Year
- KIM $3.09
- HOLX $4.46
- P/E Ratio
- KIM $27.23
- HOLX $26.51
- Revenue Growth
- KIM 10.16
- HOLX 1.29
- 52 Week Low
- KIM $17.93
- HOLX $51.90
- 52 Week High
- KIM $25.83
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- KIM 55.95
- HOLX 35.62
- Support Level
- KIM $22.23
- HOLX $65.37
- Resistance Level
- KIM $22.60
- HOLX $66.97
- Average True Range (ATR)
- KIM 0.30
- HOLX 1.10
- MACD
- KIM -0.02
- HOLX -0.36
- Stochastic Oscillator
- KIM 33.70
- HOLX 1.32
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.